⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.

Cellular Peptide Blend
KLOW
A quad-peptide combination of BPC-157, TB-500, GHK-Cu, and KPV targeting complementary angiogenic, cellular migration, extracellular matrix remodeling, and anti-inflammatory pathways in preclinical research. Premium Research Peptide.
Compound Information
Technical specifications for each component
Alpha-MSH C-Terminal Fragment
Stability Information
Where Each Stands
Sources & References
Peer-reviewed research
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al.
α-MSH Related Peptides: A New Class of Anti-Inflammatory and Immunomodulating Drugs
Luger TA, Brzoska T, Scholzen TE, et al.
Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis
Xiao B, Xu Z, Viennois E, et al.
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Pickart L, Margolina A
Thymosin Beta 4 and Cardiac Repair
Chi NC et al.
BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing
Seiwerth S et al.
BPC-157 Upregulates Growth Hormone Receptor Expression
Combined Peptide Research Literature
Individual Peptide Research Literature
⚠️Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.




